Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Artificial Intelligence In Cardiology Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The artificial intelligence in cardiology market has experienced rapid expansion in recent years. It is projected to grow from $2.72 billion in 2025 to $3.82 billion in 2026, at a compound annual growth rate (CAGR) of 40.7%. This historical growth can be attributed to factors such as increasing cardiovascular disease prevalence, the early adoption of cardiac imaging software, the expansion of wearable medical devices, the demand for quicker diagnoses, and the broadening of digital healthcare infrastructure.
The artificial intelligence in cardiology market is projected to experience substantial expansion in the coming years. This market is anticipated to reach $15.19 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 41.2%. Factors contributing to this growth during the forecast period include the uptake of remote patient monitoring, AI-powered clinical decision support, customized cardiology treatments, the incorporation of telecardiology platforms, and an emphasis on proactive cardiac care. Key trends expected over the forecast horizon encompass AI-driven cardiac imaging analysis, the rise of predictive cardiology analytics, the merging of wearable heart monitoring devices, automated arrhythmia identification, and the broadening of remote cardiac care offerings.
Download A Free Sample Report For Comprehensive Market Insights:
#Artificial Intelligence In Cardiology Market Growth Drivers And Industry Catalysts
The anticipated expansion of artificial intelligence within the cardiology market is driven by the significant incidence of cardiovascular diseases. These conditions encompass any ailments impacting the heart and its associated blood vessels. Within the field of cardiology, AI assists in identifying cardiovascular diseases, notably through aiding electrocardiogram (ECG) interpretation and pinpointing conditions such as long QT syndrome and atrial fibrillation. Furthermore, AI systems are capable of analyzing extensive datasets derived from electronic health records, mobile health devices, and various imaging sources. For example, the American Cancer Society, a US-based non-profit organization, projected in August 2025 a 90.0% rise in cardiovascular prevalence between 2025 and 2050. Additionally, data released in October 2024 by the Centres for Disease Control and Prevention (CDC), a US-based federal health agency, indicated that 919,032 individuals in the United States succumbed to cardiovascular disease in 2023, representing 1 in every 3 deaths. Consequently, the substantial impact of cardiovascular diseases serves as a key impetus for the expansion of Artificial intelligence (AI) in Cardiology.
Artificial Intelligence In Cardiology Market Segment Analysis And Revenue Opportunities
The artificial intelligence in cardiology market covered in this report is segmented –
1) By Component: Hardware, Software Solutions, Services
2) By Application: Cardiac Arrhythmia, Stroke, Ischemic Heart Disease Or Coronary Artery Disease (CAD), Other Applications
3) By End-Use: Lifescience Companies, Healthcare Payers, Healthcare Providers
Subsegments:
1) By Hardware: Imaging Devices, Wearable Devices, Diagnostic Equipment
2) By Software Solutions: Cardiac Imaging Analysis Software, Predictive Analytics Tools, Patient Management Systems, Telemedicine Platforms
3) By Services: Consulting Services, Integration And Implementation Services, Maintenance And Support Services, Training And Education Services
Artificial Intelligence In Cardiology Market Trends: What Is Shaping Future Industry Growth?
Leading firms within the artificial intelligence in cardiology market are concentrating on strategic alliances aimed at transforming heart-related research. Such strategic partnerships involve organizations pooling their respective strengths and assets to attain shared advantages and successful outcomes. An illustrative example occurred in October 2023 when the Icahn School of Medicine at Mount Sinai, a US-based medical school, declared a joint effort with Chiba Institute of Technology (CIT), a Japan-based private university. This collaboration between the two institutions endeavors to enhance understanding, prevention, and treatment of cardiovascular disease, alongside developing innovative approaches to address this widespread health issue. Mount Sinai and CIT are set to work together on establishing global clinical investigations employing artificial intelligence across various fields including interventional cardiology, heart failure, cardiac electrophysiology, cardiac imaging, and preventive cardiology. Furthermore, the research initiatives will concentrate on mitigating biases related to gender and race within the intersection of artificial intelligence and cardiovascular studies, ultimately aiming to improve patient care and health outcomes.
Artificial Intelligence In Cardiology Market Leading Players Shaping Industry Direction
Major companies operating in the artificial intelligence in cardiology market are Microsoft Corporation; International Business Machines Corporation; Siemens Healthineers; Koninklijke Philips; Ultromics Ltd; Bay Labs; Cleerly Inc.; RSIP Vision Ltd.; Idoven; Cardiologs Technologies Inc.; Viz.ai; Aidoc; Arterys Inc.; Zebra Medical Vision; AliveCor; DiA Imaging Analysis; Eko Health Inc.; Cardiomatics; UltraSight; Anumana Inc.; CardiAI Inc.; Caption Health Inc.; HeartFlow Inc.; iRhythm Technologies Inc.; Biofourmis Inc.
Access The Complete Artificial Intelligence In Cardiology Market Report:
Artificial Intelligence In Cardiology Market Largest Region By Revenue And Market Share
North America was the largest region in the artificial intelligence in cardiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cardiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
